title: Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis.
abstract: Transjugular intrahepatic portosystemic shunt (TIPS) has been the therapeutic option for severe decompensation of chronic liver disease and as a bridge to liver transplantation. The aim of this study was to analyze the complications of this procedure. The records of 47 patients (39 men) of mean age 48 years underwent TIPS procedures from 1998 to 2003 were reviewed. Forty-one patients received 45 successful TIPS; it failed in six patients. Improvement was observed in 20 of 28 patients with upper gastrointestinal bleeding (71%); 9 of 11 with ascites (82%); and 5 of 8 with impaired renal function (62%). The Child-Pugh scores improved in 6 of the 47 patients (13%). Transplantation was performed in 11 patients (23%). The complications were: encephalopathy (49%); infection (19%); renal failure (17%); TIPS migration to the portal vein (4%) and to the right atrium (4%). Mortality was 32% (15/47) over 3 months. Eight patients developed active bleeding during TIPS installation requiring mechanical ventilation and intensive care, and died within the first week. Other causes of death were sepsis (n = 2), liver failure (n = 1), accidental puncture of the Glisson's capsule leading to intra-abdominal bleeding (n = 1) and refractory upper gastrointestinal bleeding (n = 3). The latter four patients had TIPS placement failure. In conclusion, TIPS produced clinical improvement among 51% of patients with complications in 49%. The main complications were encephalopathy (49%), infection (19%), and renal failure (17%). The 3-month mortality rate after TIPS placement was 32%.
authors.affiliation: São José do Rio Preto Medical School-FAMERP, Liver Transplantation Unit and Hospital de base, FAMERP FOUNDATION, Sao Paulo, Brazil. renatosilva@famerp.br
authors.forename: R F
authors.initials: RF
authors.lastname: Silva
authors.forename: P C
authors.initials: PC
authors.lastname: Arroyo
authors.forename: W J
authors.initials: WJ
authors.lastname: Duca
authors.forename: A A M
authors.initials: AA
authors.lastname: Silva
authors.forename: L F
authors.initials: LF
authors.lastname: Reis
authors.forename: C M
authors.initials: CM
authors.lastname: Cabral
authors.forename: A
authors.initials: A
authors.lastname: Sgnolf
authors.forename: R B
authors.initials: RB
authors.lastname: Domingues
authors.forename: G T F
authors.initials: GT
authors.lastname: Barao
authors.forename: D J
authors.initials: DJ
authors.lastname: Coelho
authors.forename: M
authors.initials: M
authors.lastname: Deberaldini
authors.forename: H C C
authors.initials: HC
authors.lastname: Felício
authors.forename: R C M A
authors.initials: RC
authors.lastname: Silva
mesh_terms: D002423:Cause of Death; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects* / Q000401:mortality; D012189:Retrospective Studies; D017211:Treatment Failure